๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study

โœ Scribed by Mark L. Bernstein; V. Michael Whitehead; Susan Devine; Holcombe Grier; Faith Kung; Jeffrey Krischer; Zoanne Dreyer; Beverly Bell; Vita Land; George R. Buchanan; Charles Pratt

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
499 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ifosfamide/Carboplatin/Etoposide (ICE),
Ifosfamide/Carboplatin/Etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: A Pediatric Oncology Group phase II study
โœ Kung, Faith H.; Harris, Michael B.; Krischer, Jeffrey P. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 41 KB ๐Ÿ‘ 1 views

nary observations on ICE as salvaging therapy for refractory NHL are encouraging. More study is needed to confirm our findings and to delineate which subtypes of NHL are most responsive to ICE therapy.

Early deaths in newly diagnosed cases of
Early deaths in newly diagnosed cases of pediatric acute leukemia. A southwest oncology group study
โœ Stephen L. George; Donald J. Fernbach; Elisa T. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 444 KB ๐Ÿ‘ 2 views

A reanalysis of all ten clinical trials conducted by the Southwest Oncology Group from 1958 through 1976 in newly diagnosed pediatric acute leukemia was carried out to quantify the "early death" rate (i.e., rate of deaths during the first four weeks of remission induction) and to determine factors r